Eli Lilly Message Board - Msg: 35320504

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,045

-1.6%

2:46 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Lance Bredvold

From: zax	11/5/2025 12:50:52 PM
	1 Recommendation of 642

LLY 953.03 +5.1% Eli Lilly (LLY) to Build $3 Billion European Plant to Manufacture Weight-Loss Pill tipranks.com U.S. pharmaceutical company Eli Lilly LLY +5.08% ? has announced plans to build a $3 billion manufacturing plant in the Netherlands as it prepares to produce its highly-anticipated weight-loss pill Orforglipron. The Dutch plant is the latest investment Eli Lilly is making in the production of Orforglipron, which the company expects to receive regulatory approval in the second half of 2026. The pill is expected to be a game changer for weight-loss medications, which are currently taken by injection. Orforglipron is also expected to help Eli Lilly cement its lead over Danish rival Novo Nordisk NVO -2.09% ? in the red-hot obesity treatment market. Eli Lilly said the new Dutch facility will make the weight-loss pill for the European market and help strengthen its global supply chains. Advanced Technologies The manufacturing plant in the Netherlands will be equipped with advanced technologies such as paperless manufacturing and artificial intelligence (AI) real-time analytics. The company said the Netherlands was chosen for the manufacturing site partly due to its proximity to the European Medicines Agency as well as the availability of a skilled workforce. The new plant will be situated in Leiden Bio Science Park in Katwijk, Netherlands, and is expected to create 500 skilled manufacturing jobs and about 1,500 construction positions. Construction on the plant is expected to start in early 2026. News of the Dutch plant comes days after Eli Lilly announced a $1.2 billion expansion of its manufacturing site in Puerto Rico to boost Orforglipron production. ... tipranks.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next